PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för teduglutide. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

20 hits

Bibliografisk träff 2013-01-23

Increased intestinal absorption in the era of teduglutide and its impact on management strategies in patients with short bowel syndrome-associated intestinal failure.

Seidner DL, Schwartz LK, Winkler MF, Jeejeebhoy K, Boullata JI, Tappenden KA.

JPEN J Parenter Enteral Nutr · research support, non-u.s. gov't; journal article · DOI 10.1177/0148607112472906

Bibliografisk träff 2013-01-17

Review article: the management of long-term parenteral nutrition.

Dibb M, Teubner A, Theis V, Shaffer J, Lal S.

Aliment Pharmacol Ther · review; journal article · DOI 10.1111/apt.12209

Bibliografisk träff 2013-01-17

Safety and efficacy of teduglutide after 52 weeks of treatment in patients with short bowel intestinal failure.

O'Keefe SJ, Jeppesen PB, Gilroy R, Pertkiewicz M, Allard JP, Messing B.

Clin Gastroenterol Hepatol · research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1016/j.cgh.2012.12.029

Bibliografisk träff 2012-11-28

Pharmacokinetics of teduglutide in subjects with renal impairment.

Nave R, Halabi A, Herzog R, Schaffer P, Diefenbach J, Krause S, Berghöfer P, Lahu G, Hartmann M.

Eur J Clin Pharmacol · controlled clinical trial; research support, non-u.s. gov't; journal article · DOI 10.1007/s00228-012-1455-7

Bibliografisk träff 2012-11-26

GLP2-2G-XTEN: a pharmaceutical protein with improved serum half-life and efficacy in a rat Crohn's disease model.

Alters SE, McLaughlin B, Spink B, Lachinyan T, Wang CW, Podust V, Schellenberger V, Stemmer WP.

PLoS One · research support, non-u.s. gov't; research-article; journal article · DOI 10.1371/journal.pone.0050630

Bibliografisk träff 2012-10-23

Teduglutide and short bowel syndrome: every night without parenteral fluids is a good night.

Buchman AL.

Gastroenterology · comment; editorial · DOI 10.1053/j.gastro.2012.10.022

Bibliografisk träff 2012-10-08

Teduglutide, a glucagon-like peptide 2 analogue: a novel protective agent with anti-apoptotic and anti-oxidant properties in mice with lung injury.

Arda-Pirincci P, Oztay F, Bayrak BB, Yanardag R, Bolkent S.

Peptides · research support, non-u.s. gov't; journal article · DOI 10.1016/j.peptides.2012.09.030

Bibliografisk träff 2012-09-11

Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure.

Jeppesen PB, Pertkiewicz M, Messing B, Iyer K, Seidner DL, O'keefe SJ, Forbes A, Heinze H, Joelsson B.

Gastroenterology · clinical trial, phase iii; research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1053/j.gastro.2012.09.007

Bibliografisk träff 2012-08-19

GLP-2 receptors in human disease: high expression in gastrointestinal stromal tumors and Crohn's disease.

Körner M, Rehmann R, Reubi JC.

Mol Cell Endocrinol · research support, non-u.s. gov't; journal article · DOI 10.1016/j.mce.2012.08.008

Bibliografisk träff 2012-05-01

Teduglutide, a novel glucagon-like peptide 2 analog, in the treatment of patients with short bowel syndrome.

Jeppesen PB.

Ther Adv Gastroenterol · review-article; journal article · DOI 10.1177/1756283x11436318

Bibliografisk träff 2012-01-06

Treatment of adult short bowel syndrome patients with teduglutide.

Nørholk LM, Holst JJ, Jeppesen PB.

Expert Opin Pharmacother · review; journal article · DOI 10.1517/14656566.2012.644787

Bibliografisk träff 2011-12-01

Teduglutide for the treatment of short bowel syndrome.

Vipperla K, O'Keefe SJ.

Expert Rev Gastroenterol Hepatol · journal article · DOI 10.1586/egh.11.82

Bibliografisk träff 2011-08-19

Emerging treatment options for short bowel syndrome: potential role of teduglutide.

Tee CT, Wallis K, Gabe SM.

Clin Exp Gastroenterol · review-article; journal article · DOI 10.2147/ceg.s13906

Bibliografisk träff 2011-08-08

Maintenance of parenteral nutrition volume reduction, without weight loss, after stopping teduglutide in a subset of patients with short bowel syndrome.

Compher C, Gilroy R, Pertkiewicz M, Ziegler TR, Ratcliffe SJ, Joly F, Rochling F, Messing B.

JPEN J Parenter Enteral Nutr · research support, non-u.s. gov't; journal article · DOI 10.1177/0148607111414431

Bibliografisk träff 2011-02-11

Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome.

Jeppesen PB, Gilroy R, Pertkiewicz M, Allard JP, Messing B, O'Keefe SJ.

Gut · research-article; multicenter study; randomized controlled trial; journal article · DOI 10.1136/gut.2010.218271

Bibliografisk träff 2010-12-14

The role of glucagon-like peptide-2 on apoptosis, cell proliferation, and oxidant-antioxidant system at a mouse model of intestinal injury induced by tumor necrosis factor-alpha/actinomycin D.

Arda-Pirincci P, Bolkent S.

Mol Cell Biochem · research support, non-u.s. gov't; journal article · DOI 10.1007/s11010-010-0678-0

Bibliografisk träff 2010-12-01

Teduglutide, a glucagon-like peptide-2 analog for the treatment of gastrointestinal diseases, including short bowel syndrome.

Yazbeck R.

Curr Opin Mol Ther · journal article

Bibliografisk träff 2010-06-01

Teduglutide, a novel mucosally active analog of glucagon-like peptide-2 (GLP-2) for the treatment of moderate to severe Crohn's disease.

Buchman AL, Katz S, Fang JC, Bernstein CN, Abou-Assi SG, Teduglutide Study Group.

Inflamm Bowel Dis · research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.1002/ibd.21117

Bibliografisk träff 2009-10-21

Clinical trial simulations in pediatric patients using realistic covariates: application to teduglutide, a glucagon-like peptide-2 analog in neonates and infants with short-bowel syndrome.

Mouksassi MS, Marier JF, Cyran J, Vinks AA.

Clin Pharmacol Ther · research support, non-u.s. gov't; journal article · DOI 10.1038/clpt.2009.199

Bibliografisk träff 2009-09-22

Population pharmacokinetics of teduglutide following repeated subcutaneous administrations in healthy participants and in patients with short bowel syndrome and Crohn's disease.

Marier JF, Mouksassi MS, Gosselin NH, Beliveau M, Cyran J, Wallens J.

J Clin Pharmacol · meta-analysis; evaluation study; journal article · DOI 10.1177/0091270009342252